NCT06255197 Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
| NCT ID | NCT06255197 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 60,000 participants |
| Start Date | 2019-11-04 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60,000 participants in total. It began in 2019-11-04 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a multi-center, observational, real-world study for patients with resected lung cancers in China. With the help of a properly designed data processing algorithm and extensively performed data quality assurance, this study aims to harness the potential of real-world big data to (1) describe characteristics and treatment patterns and their evolving trends; (2) discover features associated with overall survival; and (3) address recently-emerging clinical questions.
Eligibility Criteria
Inclusion Criteria: * Age above 18. * Have received surgical resection for lung malignancies. Exclusion Criteria: * Participants whose data are of low quality, poor completeness or poor internal linkage.
Contact & Investigator
Jie He, MD-PhD
PRINCIPAL INVESTIGATOR
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS and PUMC
Frequently Asked Questions
Who can join the NCT06255197 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06255197 currently recruiting?
Yes, NCT06255197 is actively recruiting participants. Contact the research team at tanfengwei@126.com for enrollment information.
Where is the NCT06255197 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06255197 clinical trial?
NCT06255197 is sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. The principal investigator is Jie He, MD-PhD at National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS and PUMC. The trial plans to enroll 60,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.